3 brands tagged as Gastroenterology. Discover which parent companies own these brands.
Healthcare PharmaceuticalsOwned by Takeda Pharmaceutical Company
Prescription stem cell therapy originally approved in Europe for treating complex perianal fistulas in adult Crohn's disease patients, developed by TiGenix and acquired by Takeda.
Healthcare PharmaceuticalsOwned by Takeda Pharmaceutical Company
Prescription proton pump inhibitor (dexlansoprazole) for treating GERD and erosive esophagitis, manufactured by Takeda Pharmaceutical Company.
Healthcare PharmaceuticalsOwned by Merck & Co.
Over-the-counter and prescription medication for treating heartburn and acid reflux, manufactured and marketed by Merck & Co.